VIKING THERAPEUTICS INC (VKTX)

US92686J1060 - Common Stock

83.34  +2.51 (+3.11%)

Premarket: 83.15 -0.19 (-0.23%)

Buy % Consensus

88

ChartMill assigns a Buy % Consensus number of 88% to VKTX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 107.3. This target is 28.75% above the current price.
VKTX was analyzed by 16 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about VKTX.
In the previous month the buy percentage consensus was at a similar level.
VKTX was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 83.3480.80112.20107.30126.00 - -3.05% 34.63% 28.75% 51.19%
Up and Down Grades
Date Firm Action Rating
2024-03-27 Oppenheimer Maintains Outperform -> Outperform
2024-03-26 BTIG Maintains Buy -> Buy
2024-03-26 Oppenheimer Maintains Outperform -> Outperform
2024-03-26 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-15 BTIG Maintains Buy -> Buy
2024-03-15 Stifel Reiterate Buy -> Buy
2024-03-15 Maxim Group Reiterate Buy -> Buy
2024-03-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-08 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-07 Jefferies Initiate Buy
2024-02-29 Truist Securities Maintains Buy -> Buy
2024-02-28 Oppenheimer Maintains Outperform -> Outperform
2024-02-27 Raymond James Maintains Outperform -> Outperform
2024-02-27 HC Wainwright & Co. Maintains Buy -> Buy
2024-02-14 Stifel Maintains Buy -> Buy
2024-02-08 Maxim Group Maintains Buy -> Buy
2023-12-04 Truist Securities Reiterate Buy -> Buy
2023-10-02 Truist Securities Reiterate Buy -> Buy
2023-08-08 Stifel Reiterate Buy
2023-07-27 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-27 Truist Securities Reiterate Buy -> Buy
2023-05-17 Raymond James Maintains Outperform -> Outperform
2023-05-16 BTIG Maintains Buy -> Buy
2023-05-16 Oppenheimer Maintains Outperform -> Outperform
2023-05-16 Stifel Maintains Buy -> Buy
2023-05-08 HC Wainwright & Co. Reiterate Buy
2023-05-03 Roth MKM Maintains Buy
2023-04-27 Oppenheimer Reiterate Outperform
2023-04-27 HC Wainwright & Co. Maintains Buy
2023-04-25 Oppenheimer Maintains Outperform